Rowiński W, Stepkowski S, Ryffa T, Wasowska B
Arch Immunol Ther Exp (Warsz). 1978;26(1-6):1009-12.
Investigations of the specific and nonspecific immunosupression of heart transplants in rats are presented. Pretreatment of the Wistar recipient of the August heart with donor strain cellular antigen and anti-donor hyperimmune serum 11 and 10 days before transplantation caused enhancement of the heart graft in this strain combination differing in the major AgB histocompatibility locus. Combination of that protocol with non-specific immunosuppression, i.e. ATS treatment caused synergistic effect. Heart grafts in animal treated with that full protocol of biological immunosuppression survived for 50.8 days.
本文介绍了对大鼠心脏移植特异性和非特异性免疫抑制的研究。在移植前11天和10天,用供体品系细胞抗原和抗供体超免疫血清对接受奥古斯特心脏的Wistar受体进行预处理,在主要AgB组织相容性位点不同的该品系组合中,导致心脏移植物得到增强。该方案与非特异性免疫抑制(即抗胸腺细胞血清治疗)相结合产生了协同效应。用这种完整的生物免疫抑制方案治疗的动物的心脏移植物存活了50.8天。